» Articles » PMID: 38248096

Mechanisms and Potential Clinical Implications of Oral Microbiome in Oral Squamous Cell Carcinoma

Overview
Journal Curr Oncol
Publisher MDPI
Specialty Oncology
Date 2024 Jan 22
PMID 38248096
Authors
Affiliations
Soon will be listed here.
Abstract

Microorganisms in the oral cavity are abundant in the human body. At present, more than 700 species of oral microorganisms have been identified. Recently, a lot of literature has indicated that the oral microbiota plays an important role in the occurrence, development, and prognosis of oral squamous cell carcinoma (OSCC) through various mechanisms. And researchers are now trying to utilize oral microbiota in cancer diagnosis and treatment. However, few articles systematically summarize the effects of oral microbes in the diagnosis, treatment, and disease outcomes of oral cancer. Herein, we made a summary of the microbial changes at cancerous sites and placed more emphasis on the mechanisms by which the oral microbiome promotes cancerization. Moreover, we aimed to find out the clinical value of the oral microbiome in OSCC.

Citing Articles

Exploring the role of oral bacteria in oral cancer: a narrative review.

Mivehchi H, Eskandari-Yaghbastlo A, Pour Bahrami P, Elhami A, Faghihinia F, Nejati S Discov Oncol. 2025; 16(1):242.

PMID: 40009328 PMC: 11865422. DOI: 10.1007/s12672-025-01998-2.


Dysbiosis of Oral Microbiome: A Key Player in Oral Carcinogenesis? A Critical Review.

Devaraja K, Aggarwal S Biomedicines. 2025; 13(2).

PMID: 40002861 PMC: 11852717. DOI: 10.3390/biomedicines13020448.


Intra-tumoral bacteria in head and neck cancer: holistic integrative insight.

Meng Y, Deng J, Deng W, Sun Z Cancer Biol Med. 2025; 22(2).

PMID: 39969204 PMC: 11899592. DOI: 10.20892/j.issn.2095-3941.2024.0311.


Potential Antimicrobial and Cytotoxic Activity of Seed Extract.

Ramalingam S, Bakthavatchalam S, Ramachandran K, Gnanarani Soloman V, Ajmal A, Al-Sadoon M Antibiotics (Basel). 2025; 13(12.

PMID: 39766582 PMC: 11672789. DOI: 10.3390/antibiotics13121193.


Role of UFMylation in tumorigenesis and cancer immunotherapy.

Ding L, Jiang X, Li T, Wang S Front Immunol. 2024; 15:1454823.

PMID: 39247188 PMC: 11377280. DOI: 10.3389/fimmu.2024.1454823.


References
1.
Park D, Woo B, Lee B, Yoon S, Cho Y, Kim Y . Serum Levels of Interleukin-6 and Titers of Antibodies Against Could Be Potential Biomarkers for the Diagnosis of Oral Squamous Cell Carcinoma. Int J Mol Sci. 2019; 20(11). PMC: 6600294. DOI: 10.3390/ijms20112749. View

2.
Peng R, Sun Y, Zhou X, Liu S, Han Q, Cheng L . Promotes OSCC Development via the TGF-β Signaling Pathway. J Dent Res. 2022; 101(6):704-713. DOI: 10.1177/00220345211067401. View

3.
Xiong S, Qi Z, Ni J, Zhong J, Cao L, Yang K . Attenuated Salmonella typhimurium-mediated tumour targeting imaging based on peptides. Biomater Sci. 2020; 8(13):3712-3719. DOI: 10.1039/d0bm00013b. View

4.
Amit M, Yen T, Liao C, Chaturvedi P, Agarwal J, Kowalski L . Improvement in survival of patients with oral cavity squamous cell carcinoma: An international collaborative study. Cancer. 2013; 119(24):4242-8. DOI: 10.1002/cncr.28357. View

5.
Sun S, Liu J, Zhong B, Wang J, Jin X, Xu H . Topical calcineurin inhibitors in the treatment of oral lichen planus: a systematic review and meta-analysis. Br J Dermatol. 2019; 181(6):1166-1176. DOI: 10.1111/bjd.17898. View